Annual report pursuant to Section 13 and 15(d)

Document And Entity Information

v3.23.1
Document And Entity Information - USD ($)
 12 Months Ended
Dec. 31, 2022
Mar. 30, 2023
Jun. 30, 2022
Document Information Line Items      
Entity Registrant Name UNICYCIVE THERAPEUTICS, INC.    
Trading Symbol UNCY    
Document Type 10-K    
Current Fiscal Year End Date --12-31    
Entity Common Stock, Shares Outstanding   15,233,836  
Entity Public Float     $ 12,486,933
Amendment Flag false    
Entity Central Index Key 0001766140    
Entity Current Reporting Status Yes    
Entity Voluntary Filers No    
Entity Filer Category Non-accelerated Filer    
Entity Well-known Seasoned Issuer No    
Document Period End Date Dec. 31, 2022    
Document Fiscal Year Focus 2022    
Document Fiscal Period Focus FY    
Entity Small Business true    
Entity Emerging Growth Company true    
Entity Shell Company false    
Entity Ex Transition Period false    
ICFR Auditor Attestation Flag false    
Document Annual Report true    
Document Transition Report false    
Entity File Number 001-40582    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 81-3638692    
Entity Address, Address Line One 4300 El Camino Real    
Entity Address, Address Line Two Suite 210    
Entity Address, City or Town Los Altos    
Entity Address, State or Province CA    
Entity Address, Postal Zip Code 94022    
City Area Code (650)    
Local Phone Number 351-4495    
Title of 12(b) Security Common stock, par value $0.001 per share    
Security Exchange Name NASDAQ    
Entity Interactive Data Current Yes    
Auditor Firm ID 199    
Auditor Name Mayer Hoffman McCann P.C.    
Auditor Location San Diego, California